Rhinivict® nasal 0.05 mg non-prescription in your pharmacy
Kick-off for preparations against hay fever! The non-prescription Rhinivict® nasal 0.05 mg is now available in 10-ml package sizes for the short-term treatment of allergic rhinitis in your pharmacy. Hereby, the specialist Dermapharm provides a new treatment option ready for the start of the allergy season.

‘Watering eyes and itchy noses’, ‘hard times for allergy sufferers’; those or similar are the headlines as soon as alder, hazel, willow and other early flowering species release their pollen and you again get ready to never leave the house without a handkerchief.

A well-tolerated and, at the same time, affordable nasal spray can be more than helpful at this time, because seasonal hay fever is not only inconvenient, left untreated, it can become chronic and permanently damage health.

Rhinivict® nasal contains the established, proven and well-tolerated active agent Beclometasondipropionate and is ideally suited for the short-term treatment of seasonal allergic rhinitis – hay fever. The standard dose of two sprays in each nostril twice a day applies both for adults and children over 12 years old. Rhinivict® has an anti-exudative and anti-inflammatory action on the mucous membranes of the nose.

The full efficacy of Rhinivct® nasal is usually reached after only a few days; the symptoms are reduced, breathing through the nose is eased and rhinitis and sneezing decrease. This can help you to get through the pollen season more easily and decrease the risk of a step up to bronchial asthma.

1 ml of Rhinivict® nasal contains 0.555 mg Beclometasondipropionate and is available in a package size of 10 ml suspension in pharmacies without a prescription.